Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iberogast and Iberogast N on Intestinal Gas Transit in IBS and Functional Dyspepsia
NCT04656730Phase 4Completed
- Sponsor
- Vall d'Hebron University Hospital
- Start
- Sep 2020
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Iberogast, STW 5-II in irritable bowel syndrome (IBS), functional dyspepsia (FD), sponsored by Vall d'Hebron University Hospital. Started Sep 2020; status: completed.
02
Drugs
IberogastSTW 5-II
03
Conditions
irritable bowel syndrome (IBS)functional dyspepsia (FD)
Beyond the preview
Go deeper on NCT04656730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04656730.